Suchergebnisse - "Scribano, Maria Lia"

PubPharm (4)

1

Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis : IG-IBD clinical guidelines based on the GRADE methodology

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2022

von Macaluso, F. | Orlando, A. | Papi, C. | +55

2

Use of biosimilars in inflammatory bowel disease : a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2019

von Fiorino, G. | Caprioli, F. | Daperno, M. | +92

3

Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease : an international, randomised, double-blind, phase 3 non-inferiority study

enthalten in: Lancet (London, England) | 2019

von Ye, B. | Pesegova, M. | Alexeeva, O. | +17

CommentIn: Lancet. 2019 Apr 27;393(10182):1671-1672. - PMID 30929894

4

Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab : a real-life multicenter experience of compassionate use

enthalten in: Inflammatory bowel diseases | 2008

von Danese, S. | Mocciaro, F. | Guidi, L. | +13

1
[1]